MyFinsight
Home
Blog
About
Contact
Net loss applicable
to common...
-$1,834,099
Net loss
-$1,481,851
Dividend attributable to
series a, b, and c...
$352,248
Loss from operations
-$998,587
Total other expense
-$483,264
Change in fair value of
derivative and warrant...
$23,068
Change in fair value of
derivative and warrant...
$7,542
Total operating
expenses
$998,587
Interest
expense-Nonrelated Party
$216,923
Interest
expense-Related Party
$210,314
Interest expense -
amortization of debt...
$79,951
Interest expense -
amortization of debt...
$6,686
Research and
development-Nonrelated Party
$500,683
General and
administrative
$483,404
Research and
development-Related Party
$14,500
Back
Back
Income Statement
source: myfinsight.com
Cell Source, Inc. (CLCS)
Cell Source, Inc. (CLCS)